• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SLE CD4+ T 细胞中 TNFSF7(CD70)启动子的组蛋白修饰和甲基-CpG 结合域蛋白水平。

Histone modifications and methyl-CpG-binding domain protein levels at the TNFSF7 (CD70) promoter in SLE CD4+ T cells.

机构信息

Department of Dermatology, Second Xiangya Hospital, Central South University, Hunan Key Laboratory of Medical Epigenomics, Hunan, PR China.

出版信息

Lupus. 2011 Nov;20(13):1365-71. doi: 10.1177/0961203311413412. Epub 2011 Aug 24.

DOI:10.1177/0961203311413412
PMID:21865261
Abstract

In systemic lupus erythematosus (SLE), T lymphocytes overexpress CD70 (TNFSF7 gene), leading to the synthesis of autoreactive IgGs. CD70 upregulation in SLE CD4(+) T cells is associated with hypomethylation of TNFSF7 promoter. In this study, we explored histone modifications in the TNFSF7 promoter region in SLE CD4(+) T cells, and characterized the effects of a DNA methyltransferase inhibitor (5-azaC) and a histone deacetylase inhibitor (TSA) on CD70 expression. We found that CD70 mRNA was significantly increased in active lupus CD4(+) T cells, and in control cells treated with 5-azaC, TSA, or both. Histone H3 acetylation and dimethylated H3 lysine 4 (H3K4me2) levels were significantly elevated in patients with lupus, and both factors correlated positively with disease activity. MeCP2 protein levels within the TNFSF7 promoter decreased in patients with active lupus. Treatment of CD4+ T cells with 5-azaC alone significantly raised H3K4 dimethyl levels at the TNFSF7 locus. TSA treatment significantly increased H3 and H4 acetylation levels, as well as levels of H3K4 dimethylation at the TNFSF7 locus. Treatment with 5-azaC plus TSA enhanced H3 acetylation levels. These findings indicate that aberrant histone modifications within the TNFSF7 promoter may contribute to the development of lupus by increasing CD70 expression in CD4(+) T cells.

摘要

在系统性红斑狼疮(SLE)中,T 淋巴细胞过度表达 CD70(TNFSF7 基因),导致自身反应性 IgG 的合成。SLE CD4(+) T 细胞中 CD70 的上调与 TNFSF7 启动子的低甲基化有关。在这项研究中,我们探讨了 SLE CD4(+) T 细胞中 TNFSF7 启动子区域的组蛋白修饰,并研究了 DNA 甲基转移酶抑制剂(5-azaC)和组蛋白去乙酰化酶抑制剂(TSA)对 CD70 表达的影响。我们发现,活性狼疮 CD4(+) T 细胞中 CD70 mRNA 显著增加,而在对照细胞中用 5-azaC、TSA 或两者处理后也显著增加。狼疮患者的组蛋白 H3 乙酰化和组蛋白 H3 赖氨酸 4 二甲基化(H3K4me2)水平显著升高,且这两个因素与疾病活动度呈正相关。狼疮患者的 TNFSF7 启动子内 MeCP2 蛋白水平降低。单独用 5-azaC 处理 CD4+T 细胞可显著提高 TNFSF7 基因座处的 H3K4 二甲基化水平。TSA 处理可显著增加 H3 和 H4 乙酰化水平,以及 H3K4 二甲基化水平。5-azaC 和 TSA 的联合处理可增强 H3 乙酰化水平。这些发现表明,TNFSF7 启动子内异常的组蛋白修饰可能通过增加 CD4(+) T 细胞中 CD70 的表达,导致狼疮的发生。

相似文献

1
Histone modifications and methyl-CpG-binding domain protein levels at the TNFSF7 (CD70) promoter in SLE CD4+ T cells.SLE CD4+ T 细胞中 TNFSF7(CD70)启动子的组蛋白修饰和甲基-CpG 结合域蛋白水平。
Lupus. 2011 Nov;20(13):1365-71. doi: 10.1177/0961203311413412. Epub 2011 Aug 24.
2
Overexpression of the growth arrest and DNA damage-induced 45alpha gene contributes to autoimmunity by promoting DNA demethylation in lupus T cells.生长停滞与DNA损伤诱导基因45α的过表达通过促进狼疮T细胞中的DNA去甲基化而导致自身免疫。
Arthritis Rheum. 2010 May;62(5):1438-47. doi: 10.1002/art.27363.
3
Demethylation of promoter regulatory elements contributes to CD70 overexpression in CD4+ T cells from patients with subacute cutaneous lupus erythematosus.启动子调控元件的去甲基化导致亚急性皮肤型红斑狼疮患者 CD4+T 细胞中 CD70 的过度表达。
Clin Exp Dermatol. 2010 Jun;35(4):425-30. doi: 10.1111/j.1365-2230.2009.03611.x. Epub 2009 Oct 23.
4
Abnormal histone modification patterns in lupus CD4+ T cells.狼疮患者CD4+ T细胞中异常的组蛋白修饰模式。
J Rheumatol. 2008 May;35(5):804-10. Epub 2008 Apr 1.
5
Demethylation of TNFSF7 contributes to CD70 overexpression in CD4+ T cells from patients with systemic sclerosis.TNFSF7 的去甲基化导致系统性硬化症患者 CD4+T 细胞中 CD70 的过度表达。
Clin Immunol. 2012 Apr;143(1):39-44. doi: 10.1016/j.clim.2012.01.005. Epub 2012 Jan 18.
6
Coordinated changes in DNA methylation and histone modifications regulate silencing/derepression of luteinizing hormone receptor gene transcription.DNA甲基化和组蛋白修饰的协同变化调节促黄体生成素受体基因转录的沉默/去抑制。
Mol Cell Biol. 2005 Sep;25(18):7929-39. doi: 10.1128/MCB.25.18.7929-7939.2005.
7
Hypomethylation and overexpression of CD70 (TNFSF7) in CD4+ T cells of patients with primary Sjögren's syndrome.原发性干燥综合征患者 CD4+T 细胞中 CD70(TNFSF7)的低甲基化和过表达。
J Dermatol Sci. 2010 Sep;59(3):198-203. doi: 10.1016/j.jdermsci.2010.06.011. Epub 2010 Jul 7.
8
Inhibited expression of hematopoietic progenitor kinase 1 associated with loss of jumonji domain containing 3 promoter binding contributes to autoimmunity in systemic lupus erythematosus.造血祖细胞激酶 1 的表达受到抑制与含 jumonji 结构域蛋白 3 启动子结合丧失有关,导致红斑狼疮患者发生自身免疫。
J Autoimmun. 2011 Nov;37(3):180-9. doi: 10.1016/j.jaut.2011.09.006. Epub 2011 Oct 19.
9
Increased expression of TLR2 in CD4(+) T cells from SLE patients enhances immune reactivity and promotes IL-17 expression through histone modifications.系统性红斑狼疮患者 CD4+T 细胞中 TLR2 的表达增加,通过组蛋白修饰增强免疫反应性并促进 IL-17 的表达。
Eur J Immunol. 2015 Sep;45(9):2683-93. doi: 10.1002/eji.201445219. Epub 2015 Jun 26.
10
The effect of mycophenolic acid on epigenetic modifications in lupus CD4+T cells.霉酚酸对狼疮CD4+T细胞表观遗传修饰的影响。
Clin Immunol. 2015 May;158(1):67-76. doi: 10.1016/j.clim.2015.03.005. Epub 2015 Mar 17.

引用本文的文献

1
Altered CD27-related T cell subsets reflect immune imbalance in systemic lupus erythematosus.CD27相关T细胞亚群的改变反映了系统性红斑狼疮中的免疫失衡。
Immunol Res. 2025 May 17;73(1):83. doi: 10.1007/s12026-025-09637-2.
2
CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives.用于系统性红斑狼疮的嵌合抗原受体T细胞疗法:现状与未来展望
Front Immunol. 2024 Dec 19;15:1476859. doi: 10.3389/fimmu.2024.1476859. eCollection 2024.
3
Angiotensin receptor blockers modulate the lupus CD4+ T cell epigenome characterized by TNF family-linked signaling.
血管紧张素受体阻滞剂可调节以肿瘤坏死因子家族相关信号为特征的狼疮CD4⁺ T细胞表观基因组。
JCI Insight. 2024 Dec 17;10(3):e176811. doi: 10.1172/jci.insight.176811.
4
Autoimmune disease: a view of epigenetics and therapeutic targeting.自身免疫性疾病:表观遗传学与治疗靶点的视角
Front Immunol. 2024 Nov 13;15:1482728. doi: 10.3389/fimmu.2024.1482728. eCollection 2024.
5
Epigenetic Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus.系统性红斑狼疮发病机制中的表观遗传失调。
Int J Mol Sci. 2024 Jan 13;25(2):1019. doi: 10.3390/ijms25021019.
6
Noval advance of histone modification in inflammatory skin diseases and related treatment methods.组蛋白修饰在炎症性皮肤病中的最新进展及相关治疗方法。
Front Immunol. 2024 Jan 3;14:1286776. doi: 10.3389/fimmu.2023.1286776. eCollection 2023.
7
Methyl Donor Micronutrients: A Potential Dietary Epigenetic Target in Systemic Lupus Erythematosus Patients.甲基供体微量营养素:系统性红斑狼疮患者潜在的饮食表观遗传学靶点。
Int J Mol Sci. 2023 Feb 6;24(4):3171. doi: 10.3390/ijms24043171.
8
The frequency of differentiated CD3CD27CD28 T cells predicts response to CART cell therapy in diffuse large B-cell lymphoma.分化型 CD3CD27CD28 T 细胞的频率可预测弥漫性大 B 细胞淋巴瘤对 CART 细胞治疗的反应。
Front Immunol. 2023 Jan 9;13:1004703. doi: 10.3389/fimmu.2022.1004703. eCollection 2022.
9
Myeloid-derived suppressor cell: A crucial player in autoimmune diseases.髓系来源的抑制性细胞:自身免疫性疾病中的关键角色。
Front Immunol. 2022 Dec 9;13:1021612. doi: 10.3389/fimmu.2022.1021612. eCollection 2022.
10
Lysine Acetylation/Deacetylation Modification of Immune-Related Molecules in Cancer Immunotherapy.赖氨酸乙酰化/去乙酰化修饰在癌症免疫治疗中的免疫相关分子。
Front Immunol. 2022 May 2;13:865975. doi: 10.3389/fimmu.2022.865975. eCollection 2022.